logo

For the Inventor, By the Inventor

Sohag, Egypt

Antar Ahmed Abdelhamid Ahmed

USPTO Granted Patents = 282 

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 29(Granted Patents)

Forward Citations (Not Self Cited) = 2(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Sohag, EG (2023 - 2024)
  • Al-Baha, EG (2024)
  • Al-Baha, SA (2024)
  • Al-Ahsa, SA (2024)
  • Al Hasa, SA (2024)

Company Filing History:

goldMedal282 out of 3,212 
 
King Fahd University of Petroleum and Minerals
 patents

Years Active: 2023-2025

Loading Chart...
Areas of Expertise:
Antimicrobial Compounds
Eco-Friendly Insecticides
Antioxidant Compounds
Anti-Cancer Agents
Imidazole Derivatives
Oxadiazole Compounds
Acridine Derivatives
Thiazole Compounds
Phenyl Compounds
Triazole Compounds
Nicotinonitrile Derivatives
Benzothiophene Compounds
282 patents (USPTO):Explore Patents
1. 12291514 - Ethyl 2-[9-(2-hydroxypyridin-3-yl)-3,6-diphenyl-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound (2025-05-06),
2. 12264128 - Acid as an antioxidant compound (2025-04-01),
3. 12264127 - 8-((3-formyl-4-hydroxyphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound (2025-04-01),
4. 12202814 - 9-(6-flouro-2-hydroxypyridin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound (2025-01-21),
5. 12195430 - 6-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)hexanoic acid as an antimicrobial compound (2025-01-14),
6. 12180204 - 2-(benzo[d]thiazol-2-yl)-N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound (2024-12-31),
7. 12180203 - 2-(benzo[d]thiazol-2-yl)-n'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound (2024-12-31),
8. 12180202 - 2-[(1,3-benzothiazol-2-yl)imino]-5,5-diphenylimidazolidin-4-one as an antimicrobial compound (2024-12-31),
9. 12180201 - 2-(benzo[d]oxazol-2-yl)-N'-(isonicotinoyloxy)acetimidamide as an antimicrobial compound (2024-12-31),
10. 12180200 - 2-(benzo[d]oxazol-2-yl)-n'-(isonicotinoyloxy)acetimidamide as an antimicrobial compound (2024-12-31),
11. 12180199 - 2-(benzo[d]oxazol-2-yl)-n'-(isonicotinoyloxy)acetimidamide as an antimicrobial compound (2024-12-31),
12. 12180181 - 4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound (2024-12-31),
13. 12180180 - 4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound (2024-12-31),
14. 12180173 - 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound (2024-12-31),
15. 12180172 - [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound (2024-12-31),

Title: Inventor Profile: Antar Ahmed Abdelhamid Ahmed

Introduction: Antar Ahmed Abdelhamid Ahmed is a renowned inventor hailing from Sohag, Egypt. His innovative spirit and dedication to creating groundbreaking solutions have earned him recognition in the field of inventions.

Latest Patents: Antar Ahmed Abdelhamid Ahmed holds several patents in various industries, showcasing his versatility and creativity in inventing new technologies to address modern challenges.

Career Highlights: With a successful career in the field of inventions, Antar Ahmed Abdelhamid Ahmed has demonstrated a keen ability to identify gaps in the market and develop unique solutions to fill them. His contributions have significantly impacted the way we approach problem-solving in different sectors.

Collaborations: Antar Ahmed Abdelhamid Ahmed has collaborated with leading experts and organizations in the industry to bring his inventions to life. His collaborative efforts have led to the successful implementation of innovative ideas and technologies in the market.

Conclusion: Antar Ahmed Abdelhamid Ahmed's passion for

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…